loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2008_293___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Seqens

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 CU Chemie Uetikon GmbH Lahr DE (1)

    filter

    01 Thiamazole (1)

    filter

    01 France (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    CU Chemie Uetikon GmbH Lahr DE

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Thiamazole

    PDF Supplier PDF
    URL Supplier Web Content
    Other DMF CA, CN
    CEP 2008-293 - Rev 01
    Valid
    Chemical
    2023-12-04
    1706
    Seqens Company Banner

    CPhI North America

    Exhibiting

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for CEP 2008-293 - Rev 01 of Cu Chemie Uetikon Gmbh Lahr De

    Looking for Certificates of Suitability (CEPs) for CEP 2008-293 - Rev 01 of Cu Chemie Uetikon Gmbh Lahr De 1

    20

    Cu Chemie Uetikon Gmbh Lahr De, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    One of their significant offerings is Thiamazole, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2008-293 - Rev 01

    This Chemical Type CEP, issued on December 04, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1706 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY